Silver Nanoparticles in Multidrug Resistant Bacteria
Completed
- Conditions
- Multidrug Resistent Bacteria
- Registration Number
- NCT04431440
- Lead Sponsor
- Assiut University
- Brief Summary
Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. The present study investigated the bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and Vancomycin resistant Staph aureus (VRSA)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Intensive care patients
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method bactericidal effect of silver nanoparticles on multidrug resistant bacteria 24 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Assiut university
🇪🇬Assiut, Egypt
Assiut university🇪🇬Assiut, Egypt